The Glomerular Disease Study & Trial Consortium (GlomCon) is a mission-driven nonprofit charitable 501(c)(3) organization registered in the state of Pennsylvania, U.S.A. Our mission is to provide medical education based on the best available evidence, free of commercial and ideological bias, and create a platform for research collaboration among clinicians, academics, and industry partners guided by patients’ and their caregivers’ needs.
In 2016 GlomCon was started as an academic research collaborative at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston. Since then, GlomCon has grown to a global consortium that includes a multi-site real-world evidence study group, a certificate-based virtual glomerular disease fellowship program, weekly clinical and scientific seminars led by leading experts in the field of glomerular diseases, and an open access publishing portal, among others.
Luminaries in nephrology and nephropathology, experts in glomerular diseases, and phenomenal medical educators provide exceptional clinical and scientific seminars of the highest quality. Therefore, GlomCon has become a household name to many academic and private practice nephrologists and almost every training program in the U.S and abroad.
As of January 2022, GlomCon has conducted more than 180 life seminars spanning from case-specific discussions of diagnostic and therapeutic challenges, review of new scientific discoveries, and introduction of new concepts and paradigms by leading experts in the field of glomerular diseases and nephrology. The weekly attendance of these life seminars enjoys one of the highest attendance rates in this field (120 – 240 life participants from academia, private practice, industry, and government). Nevertheless, our global audience has watched the archived seminars on YouTube more than 379,000 times (check out our YouTube channel here).
In 2020 GlomCon introduced a certificate-based Virtual Fellowship Program to support a structured and curriculum-based approach in glomerular disease training irrespective of local access to experts and educators. To learn more, visit edu.glomcon.org.
In 2021 GlomCon was incorporated as a charitable 501(c)(3) nonprofit organization to sustain current achievements and support our vision for a better future for patients with glomerular diseases.
We, a group of passionate clinicians, pathologists, and researchers, believe nephrology to be at the dawn of a new era in diagnostic and therapeutic opportunities. And we are ready to seize any opportunity that can advance the care of patients with glomerular diseases.
We invite kidney enthusiasts, innovators, creators, and entrepreneurs to join us and participate in our Mission and participate in fostering a global network of emerging leaders.
You may also support us through a donation (tax-deductible in the U.S.A) which we will use toward helping the web-, online educational-, and IT- infrastructure that holds the collaboration together.